Nisa Investment Advisors, LLC Akebia Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $21.8 Billion
- Q2 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 3,021 shares of AKBA stock, worth $10,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,021
Previous 666
353.6%
Holding current value
$10,029
Previous $1,000
900.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AKBA
# of Institutions
166Shares Held
100MCall Options Held
98.6KPut Options Held
320K-
Vanguard Group Inc Valley Forge, PA14.6MShares$48.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.81MShares$22.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$20.2 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$19.1 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $610M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...